ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
8.21
+0.52 (6.76%)
Dec 20, 2024, 4:00 PM EST - Market closed
ORIC Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 579 | 502 | 265 | 579 | 1,240 | - | |
| Market Cap Growth | 119.16% | 89.55% | -54.26% | -53.32% | - | - | |
| Enterprise Value | 317 | 285 | 84 | 302 | 1,053 | - | |
| Last Close Price | 8.21 | 9.20 | 5.89 | 14.70 | 33.85 | - | |
| PB Ratio | 2.11 | 2.24 | 1.19 | 2.12 | 4.28 | - | |
| P/TBV Ratio | 2.64 | 2.24 | 1.19 | 2.12 | 4.28 | - | |
| Debt / Equity Ratio | 0.04 | 0.05 | 0.05 | 0.05 | - | - | |
| Quick Ratio | 12.82 | 10.18 | 13.40 | 15.64 | 32.61 | 16.65 | |
| Current Ratio | 13.15 | 10.39 | 13.68 | 15.87 | 32.96 | 16.81 | |
| Return on Equity (ROE) | -45.98% | -45.11% | -35.99% | -27.98% | -39.02% | -41.10% | |
| Return on Assets (ROA) | -29.22% | -27.74% | -19.87% | -16.50% | -15.69% | -25.36% | |
| Return on Capital (ROIC) | -31.07% | -29.54% | -20.86% | -17.14% | -16.33% | -27.30% | |
| Earnings Yield | -20.69% | -20.06% | -33.66% | -13.60% | -5.94% | - | |
| FCF Yield | -18.97% | -17.24% | -29.16% | -10.45% | -3.70% | - | |
| Buyback Yield / Dilution | -41.07% | -29.75% | -4.48% | -72.97% | -1055.26% | -9.53% | |
| Total Shareholder Return | -41.07% | -29.75% | -4.48% | -72.97% | -1055.26% | -9.53% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.